Sagimet Biosciences earnings were -$47.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SGMT earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$14.0M, up 31% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SGMT reported annual earnings of -$51.0M, with 12% growth. The next SGMT earnings date is Nov 12, 2026.
Sagimet Biosciences Earnings Reports & History FAQ
What were Sagimet Biosciences's earnings last quarter?
On SGMT's earnings call on Aug 12, 2026, Sagimet Biosciences (NASDAQ: SGMT) reported Q2 2026 earnings per share (EPS) of -$0.26, up 18.75% year over year. Total SGMT earnings for the quarter were -$13.95 million. In the same quarter last year, Sagimet Biosciences's earnings per share (EPS) was -$0.32.
The next SGMT earnings call is Nov 12, 2026. Add SGMT to your watchlist to be reminded of Sagimet Biosciences's next earnings date.
Is Sagimet Biosciences profitable or losing money?
As of the last Sagimet Biosciences earnings report, Sagimet Biosciences is currently losing money. Sagimet Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$47.08 million, a 20.72% decrease year over year.
What was SGMT's earnings growth in the past year?
As of Sagimet Biosciences's earnings date in Aug 12, 2026, Sagimet Biosciences's earnings has grown year over year. SGMT earnings in the past year totalled -$47.08 million.
What are Sagimet Biosciences's earnings expectations?
The current EPS estimate for Sagimet Biosciences's earnings report in Nov 12, 2026 is -$0.25.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.